Resources and Information
»Glaucoma Watch
Introduction to the National Glaucoma Society
"The excellence in glaucoma care starts in your chair, every day." Listen to Dr. Jim Thimons talk about the National Glaucoma Society.
read more
»Industry News
New FDA Approval for Lumigan
The FDA has approved Allergan's glaucoma medication, Lumigan for first-line treatment for elevated intraocular pressure associated with ocular hypertension or open angle glaucoma.
read more
»Clinical Guidelines
More CCT
An interesting retrospective study in the Journal of Glaucoma, April 2006, addresses the importance of CCT as a predictor of localized RNLF defects at initial evaluation for NTG.
read more
»In Your Office
BCBS Coverage of SCODI Services
Starting July 1, Blue Cross Blue Shield of Massachusetts will extend coverage to patients for Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) services, CPT 92135, provided by Doctors of Optometry.
read more
»Clinical Guidelines
The Role of CCT in Glaucoma Patients
The Ocular Hypertension Study (OHTS) was the first multi-center trial to demonstrate the relationship between CCT and risk of progression to glaucoma in Ocular Hypertensive patients. While this information has established a new standard in the care for our patients, it has also opened discussion regarding the usefulness of this information in areas other than Ocular Hypertensives.
read more
»Glaucoma Watch
Neckties and IOP: The Controversy Continues
Clinicians have been aware of the increase of intraocular pressure from tight collars and neckties. A new study published in the Journal of Glaucoma, December 2005, by Talty and O’Brien gives us further information.
read more
»Glaucoma Watch
From Ocular Hypertension to Glaucoma: How to Predict Conversion
The treatment of Ocular Hypertension in clinical practice is an area that has received significant attention in the last decade in order to identify Risk Factors that mediate progression to glaucoma.
read more
»Clinical Guidelines
CCT: Is is time to say YES?
The Ocular Hypertension Treatment Study established the role of CCT in clinical practice for our ocular hypertensive patients, but to date the impact of this technology in a general practice had not been elaborated.
read more